Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility

Sanofi

Status and phase: Completed; Phase 3

Conditions: Hygiene

Treatments: Drug: Dermacyd PH_DETINLYN (Lactic Acid)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00785655

LACAC_L_04299

Details and patient eligibility

About

To demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Sweet Flower.

Enrollment: 53 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Phototype Skin I,II, III e IV
• Integral skin test in the region;
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria

• Lactation or gestation
• Use of Antiinflammatory and/or immunossupression drugs
• Personnel history of atopy

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

• History of sensitivity or irritation for topic products;
• Active cutaneous disease;
• Use of new drugs or cosmetics during the study The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

53 participants in 1 patient group

1

Experimental group

Description:

Dermacyd PH_DETINLYN (Lactic Acid)

Treatment:

Drug: Dermacyd PH_DETINLYN (Lactic Acid)